Monthly E-newsletter - August 2020
Newsletter on Pharma advancement
Pharma Advancment news letter subscribe Advertise with us
August - 2020Ι Volume 8 I Pharma Advancement E-newsletter
  Pharma Advancement on LinkedIn Pharma Advancement on Facebook
Latest Updates
AGC Biologics Completes PPQ Manufacturing Campaign with Provention Bio for Type 1 Diabetes Product Candidate, Teplizumab
AGC Biologics, a leading global Biopharmaceutical CDMO, achieved the on-schedule completion of a drug substance Process Performance Qualification (PPQ) campaign, focused on teplizumab (PRV-031) for partner Provention Bio, Inc.,
Intravacc, Therapyx Develop First Prophylactic Gonorrhea Vaccine
Catalent and AstraZeneca Enter Vaccine Manufacturing Deal
Roche, Regeneron Partner to Increase Global Supply of REGN-COV2
Siemens, Perceptive Engineering & PSE Join Medicines Manufacturing Innovation Centre
Q BioMed Initiates GMP Production of Novel COVID-19 Therapeutic
PharmaSources Launches the Export-Driven Event CPhI & P-MEC China E-Trade Season
Cergentis expands product portfolio
Vetter expands its Development Service with new site in Austria
Advertise in Our Next Issue - Contact
Thermo Fisher Scientific Launches New Deployment Model to Optimize LIMS Implementation in the Amazon Web Services Cloud

Thermo Fisher Scientific has expanded deployment model options for SampleManager LIMS software, offering laboratories end-to-end support of the software deployment in the Amazon Web Services (AWS) Cloud.

View All Press Releases
Popular Events

9th Annual Publication and Clinical Trial Transparency 2020
2020-09-24 - 2020-08-25

Medical Fair Asia 2020
2020-12-09 - 2020-12-11
Marina Bay Sands , Singapore, Singapore

Digital Pathology & AI Congress USA
2020-11-19 - 2020-11-20
New York, USA

CPhI China 2020
2020-12-16 - 2020-12-18
SNIEC , China

BePharma 2020
2020-09-17 - 2020-09-19
Hilton Mexico City Reforma , Mexico

Pharma CI USA Conference & Exhibition 2020
2020-09-30 - 2020-10-01
Newark Liberty International , NJ, USA


Editorial Inquiries

Advertising Inquiries

Untitled Document